ClinicalTrials.Veeva

Menu

IRIS-BVS AMI Registry (IRIS BVS AMI)

D

Duk-Woo Park, MD

Status

Terminated

Conditions

Coronary Artery Disease
Arterial Occlusive Diseases
Cardiovascular Diseases

Treatments

Device: Bioresorbable Vascular Scaffold

Study type

Observational

Funder types

Other

Identifiers

NCT02699671
AMCCV2016-01

Details and patient eligibility

About

The purpose of this study is to evaluate the relative effectiveness and safety of Bioresorbable Vascular Scaffold in acute myocardial infarction compared to other (drug eluting stents) DES.

Enrollment

69 patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 19 and more
  • Acute myocardial infarction
  • Intervention with Bioresorbable Vascular Scaffold
  • Agreed with written informed consent form

Exclusion criteria

  • Bypass graft surgery (CABG) recommended
  • Lesion with previous bypass graft surgery (CABG)
  • Severe calcification and/or severe tortuosity
  • Contraindication to antiplatelet agent or Inability to take dual antiplatelet therapy within 1 year
  • Life expectancy of 1year and under
  • Subjects scheduled to receive cardiac surgery or serious non-cardiac surgery
  • Cardiac shock

Trial design

69 participants in 1 patient group

acute myocardial infarction
Treatment:
Device: Bioresorbable Vascular Scaffold

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems